Morishita Jintan Co Ltd

Morishita Jintan maintains a conservative capital structure with a debt-to-equity ratio of 0.11, indicating minimal leverage and strong equity backing. The company's liquidity position is robust, with a current ratio of 2.89 and cash and equivalents of ¥1.94 billion, which provides a buffer against short-term obligations. The price-to-book ratio of 0.74 suggests the company is trading at a discount to its book value, potentially signaling undervaluation or asset-heavy operations. Profitability metrics show a return on equity (ROE) of 4.5% and a return on assets (ROA) of 3.06%, both below the typical thresholds for high-performing firms in the Food Processing industry. The gross profit margin of 46.8% (¥5.97 billion on ¥12.77 billion revenue) is in line with industry norms, but the operating margin of 5.5% (¥707 million on ¥12.77 billion revenue) is relatively low, indicating potential inefficiencies in cost control or pricing power. The company operates in two segments: Healthcare and Capsules. The Healthcare segment distributes health-related products through online and domestic channels, while the Capsules segment provides capsule bulks to food and pharmaceutical manufacturers. Revenue concentration data is not explicitly provided, but the dual-segment model suggests diversification across product lines and customer bases. Growth trajectory appears modest, with no significant revenue acceleration in the most recent period. The company reported ¥12.77 billion in revenue, with a net income of ¥547 million. While the price-to-earnings ratio of 16.53 is in line with the industry median, the low ROE and ROA suggest limited capital efficiency. The company's free cash flow of ¥242 million supports reinvestment or shareholder returns, but the capital expenditure of -¥679 million indicates asset disposals or cost reductions. Risk factors are minimal, with low liquidity and dilution risk scores. The company has no immediate filing-based liquidity or dilution flags, and the low debt-to-equity ratio reduces exposure to interest rate volatility. The absence of dilution risk is reinforced by the identical basic and diluted share counts, indicating no near-term threat to ownership concentration. Recent events include the latest financial filing, which disclosed the company's revenue and earnings performance. No material regulatory or geopolitical events were identified in the input data, and the company's exposure to external shocks appears limited. The company's operations are primarily domestic, reducing exposure to currency and trade policy risks.